Risk of a second cancer after early breast cancer is low, reports research Dr. Kamal Kant Kohli28 Aug 2025 5:00 AM ISTFor women diagnosed with early breast cancer, the long-term risk of developing a second primary cancer is low (around 2-3% greater than women in the...
Cancer care from oncology subspecialists has doubled since 2008, reveals research Dr. Kamal Kant Kohli26 Aug 2025 8:30 PM ISTA retrospective cohort study aimed to quantify trends in oncologist subspecialization and assess differences in subspecialized cancer care utilization...
New cancer drug boosts effectiveness of chemotherapy-even in resistant tumours: Study Dr. Kamal Kant Kohli22 Aug 2025 10:00 PM ISTA groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours. The drug works by disarming a...
Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients: Study Dr. Kamal Kant Kohli21 Aug 2025 11:30 PM ISTFor some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening...
Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor Deeksha Bhandari21 Aug 2025 12:30 PM ISTIn this video, Dr. Akhil Kapoor, Medical Oncologist at Tata Memorial Centre, Varanasi, Uttar Pradesh, discusses a real-world case study of...
Padcev plus Keytruda significantly improves survival for certain patients with bladder cancer when given before, after surgery: Pfizer Ruchika Sharma17 Aug 2025 10:30 AM ISTNew York: Pfizer Inc. and Astellas Pharma Inc. have announced positive topline results from the Phase 3 EV-303 clinical trial (also known as...
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Rectal Cancer - Dr. Poulami Basu Deeksha Bhandari7 Aug 2025 8:30 AM ISTIn this video, Dr Poulami Basu, Medical Oncologist at Netaji Subhas Chandra Bose Cancer Hospital, Pancha Sayar, Kolkata, presents a real-world...
Cancer immunotherapy linked to rare liver complication, study warns Dr. Kamal Kant Kohli2 Aug 2025 7:30 AM ISTA global study reveals that cutting-edge cancer immunotherapies, while lifesaving, carry a hidden risk: they may trigger cholestasis, a serious liver...
Understanding how a key protein helps aggressive blood cancer grow, paving the way for targeted therapies: Study Dr. Kamal Kant Kohli27 July 2025 9:15 PM ISTAcute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
A new cell therapy for leukaemia shows high efficacy and safety in the laboratory: Study Dr. Kamal Kant Kohli24 July 2025 8:30 PM ISTT-cell Acute Lymphoblastic Leukaemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and adults. It is...
Stevia leaf extract has potential as anticancer treatment, researchers find Dr. Kamal Kant Kohli23 July 2025 4:45 AM ISTStevia may provide more benefits than as a zero-calorie sugar substitute. When fermented with bacteria isolated from banana leaves, stevia extract...
AstraZeneca-Daiichi Sankyo Datroway gets USFDA accelerated nod for previously treated advanced EGFR-mutated non-small cell lung cancer Ruchika Sharma26 Jun 2025 11:20 AM ISTCambridge: AstraZeneca and Daiichi Sankyo have announced that Datroway (datopotamab deruxtecan or Dato-DXd) has...
